Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.2K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

16
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
16
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

890
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
890
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

1.6K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

17
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
17
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

1.3K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cause of a colorectal polyp in the caecum.

Gut·2025
Same author

Medication use and risk of reflux oesophagitis.

BMJ open gastroenterology·2024
Same author

Facile Synthesis of Novel Short-Chain Ligand-Capped Colloidal Metal Oxide Nanoparticles for Printed Flexible Devices.

ACS applied materials & interfaces·2024
Same author

Prevalence and Risk Factors of Constipation Symptoms among Patients Undergoing Colonoscopy: A Single-Center Cross-Sectional Study.

Digestion·2024
Same author

Vincazalidine A, a unique bisindole alkaloid from Catharanthus roseus.

Journal of natural medicines·2024
Same author

Novel adjustable traction "noose knot" method for colorectal endoscopic submucosal dissection.

Endoscopy·2024

Related Experiment Video

Updated: Apr 21, 2026

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

1.1K

Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor.

Tomoyuki Yada1, Koichi Ito, Keigo Suzuki

  • 1Department of Gastroenterology, Kohnodai Hospital, National Center for Global Health and Medicine, 1-7-1 Kohnodai, Ichikawa, Chiba, 272-8516, Japan, tomoyuki0618@yahoo.co.jp.

Clinical Journal of Gastroenterology
|November 8, 2014
PubMed
Summary

Abnormally high serum pepsinogen II (PG II) levels, not linked to gastritis, indicated a duodenal tumor. Tumor resection normalized PG II levels, offering new diagnostic insights for duodenal tumors.

More Related Videos

Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions
03:34

Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions

Published on: February 9, 2024

1.1K
Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
10:10

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

16

Related Experiment Videos

Last Updated: Apr 21, 2026

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

1.1K
Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions
03:34

Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions

Published on: February 9, 2024

1.1K
Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
10:10

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

16

Area of Science:

  • Gastroenterology
  • Oncology
  • Biochemistry

Background:

  • Serum pepsinogen (PG) levels are established markers for chronic atrophic gastritis and gastric cancer risk.
  • However, serum PG levels can be influenced by conditions beyond gastritis.
  • This study explores an atypical cause of elevated PG levels.

Observation:

  • A patient presented with markedly elevated serum PG II levels (168.8 ng/mL).
  • Endoscopic and histopathological examinations revealed no signs of gastritis, inflammation, or H. pylori infection.
  • A large duodenal tumor was subsequently discovered.

Findings:

  • Post-duodenal tumor resection, serum PG II levels significantly decreased, returning to normal (10.1 ng/mL).
  • The elevated PG II levels were hypothesized to result from the duodenal tumor impeding secretion from Brunner's glands into the lumen, increasing bloodstream concentration.
  • This is the first reported case detailing serum PG II dynamics before and after large duodenal tumor resection.

Implications:

  • This case highlights that elevated serum PG II can be an indicator of duodenal pathology, not solely gastric conditions.
  • It suggests a potential diagnostic role for monitoring serum PG II levels in cases of unexplained elevations.
  • Understanding PG II dynamics provides valuable insights for diagnosing and managing duodenal tumors.